Repurposed drug enters clinical trial for Lewy body dementia
Researchers in the US have launched a clinical trial to test a drug with the potential to slow the progression of Lewy body dementia.
Test to detect early Parkinson's given FDA Breakthrough Device Designation
The biotech company Amprion have developed a test to detect the early signs of Parkinson's, before the onset of symptoms, which they hope will be ready to market in the next 18 months.
New study suggests that having bipolar disorder increases the risk of Parkinson's
People with bipolar disorder are almost 7 times more likely to develop Parkinson's than those without the condition, according to new research published in the journal Neurology.
New insights into the link between the appendix and Parkinson's
The media reports on a large-scale study that suggests the removal of the appendix may increase the risk of Parkinson's.
Phase II trial is underway investigating a gene therapy for Parkinson's
Axovant Gene Therapies Ltd., a company developing innovative gene therapies, has announced they are entering the next stage of a phase II gene therapy trial for Parkinson's.
Blood pressure drug fails in phase 3 Parkinson's trial
The STEADY-PD clinical trial has failed to show that isradipine is an effective treatment to slow or stop progression in early Parkinson's.
Malaria drug shows promise in Parkinson's model in the lab
Research shows that problems with recycling in brain cells in Parkinson's are overcome by the malaria drug clioquinol.
Experimental spinal stimulation shows promise for reducing freezing
Results from a trial of spinal cord stimulation carried out in Ontario, Canada highlights its potential for improving walking in Parkinson's.
‘Super smeller’ research moves us closer to a diagnostic test for Parkinson’s
Researchers have identified small molecules secreted by the skin that are maybe responsible for a unique scent in people with Parkinson's.